Carol Gregorio

Department Head, Cellular and Molecular Medicine
Vice Dean, Innovation and Development
Co-Director, Sarver Heart Center
Director, Molecular Cardiovascular Research Program
Professor, Cellular and Molecular Medicine
Professor, Molecular and Cellular Biology
Professor, BIO5 Institute

Carol Gregorio, PhD, performs research in her lab that is focused on identifying the components and molecular mechanisms regulating actin architecture in cardiac and skeletal muscle during normal development and disease.  Control of actin filament lengths and dynamics is important for cell motility and architecture and is regulated in part by capping proteins that block elongation and depolymerization at both the fast-growing (barbed) and slow-growing (pointed) ends of the filaments.  Striated muscle is an ideal model system to test for the functional properties of various actin regulatory proteins due to the precise organization and polarity of cytoskeletal components within repeating sarcomeric units (for example, the ~1 mm long actin filaments are easily resolved by light microscopy).  Using this system, she can combine advanced cell biological and biochemical approaches with direct tests of physiological function in live beating muscle cells.

The research objectives of the laboratory can be broadly summarized as follows: 1) understanding the cellular mechanisms involved in the assembly, regulation and maintenance of contractile proteins in cardiac muscle in health and disease; 2) deciphering the mechanisms critical for precisely specifying and maintaining the lengths of actin filaments; 3) discovery of novel models of de novo cardiac muscle assembly, with special emphasis on differentiating murine embryonic stem (ES) cells to study all stages of heart muscle development. Actin is an indispensable structural element of cells and is the major component of heart muscle. Changes in actin, caused by genetic mutations, which have been identified in humans, are a frequent cause of several forms of cardiomyopathy.  Her lab is determining how genetic defects in this protein affect muscle force generation and muscle contraction, leading to sudden cardiac death.